CMIC Services in the Asia Pacific Region
Involved in over 13 Countries throughout the APAC Area
CMIC’s Asia Pacific Reach, Beyond Japan
CMIC supports over 135 active clinical trials across more than 13 countries in the APAC region. Over the past 5 years, we have supported clinical trials over a range of therapeutic areas, with specialization in oncology, cardiovascular diseases, ophthalmology, endocrinology and metabolic diseases, and dermatology. We can help you navigate the regulatory landscape, identify clinical trial sites, and recruit patients. We also offer a variety of cost-saving solutions to help you get your product to market faster, as the APAC market offers numerous benefits, including faster approvals.
Discover CMIC APAC Solutions
The Asia-Pacific region offers several advantages that make it an attractive destination for clinical trials. With its vast population, diverse demographics, and cutting-edge research institutions, an increasing number of pharmaceutical and biotech companies are seeking to conduct clinical trials in Asia. As a full service clinical research organization, CMIC Group can support you with:
- Strategic Consulting
- Regulatory Consulting and Regulatory Affairs
- Clinical Trials
- Clinical Research
- Investigational Product Manufacturing (Korea)
- Commercial Supply (Korea)
- Post-marketing Surveillance